Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
528 studies found for:    ferritin
Show Display Options
Rank Status Study
1 Unknown  Efficacy and Safety of Efficacy and Safety of Continued Iron Chelation Therapy In Poly-transfused Thalassemia Patients With Low Serum Ferritin (< 500 ng/ml)
Conditions: Beta-thalassemia;   Serum Ferritin;   Iron Chelation Therapy
Intervention: Drug: desferal, ferriprox, blood transfusion
2 Recruiting Serum Ferritin Concentration and Fetal MCA Doppler as Predictors for Preterm Delivery
Condition: Preterm Delivery
Interventions: Procedure: serum ferritin;   Procedure: MCA Doppler
3 Active, not recruiting Maternal Serum Ferritin and Low Neonatal Birth Weight
Condition: IUGR
Intervention:
4 Recruiting Glycosylated Ferritin in Macrophagic Activation Syndromes
Conditions: Still's Disease, Adult-Onset;   Sepsis;   Macrophagic Activation Syndrome
Intervention:
5 Completed DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Conditions: Anemia, Iron-Deficiency;   Kidney Failure, Chronic;   Hemodialysis
Intervention: Drug: Sodium ferric gluconate,
6 Completed The Prognostic and Diagnostic Value of Ferritin in Critically Ill Patients With Special Focus on Underlying Hemophagocytic Lymphohistiocytosis
Condition: Hemophagocytic Lymphohistiocytosis
Intervention:
7 Completed HEPFER-Evaluation of a New Phenotypic Biological Marker in Genetic Type 1 Hemochromatosis
Condition: Hereditary Hemochromatosis C282Y Homozygous
Intervention:
8 Recruiting Hepcidine and Iron Deficiency in Critically Ill Patients
Conditions: Anemia;   Critical Illness;   Hospitalized for 5 Days or More
Interventions: Biological: hepcidin;   Biological: ferritin and transferrin saturation
9 Suspended Interest of Biofer ® Compound Used in Blédilait Follow on Milk in Infant With Latent Iron Deficiency
Condition: Latent Iron Deficiency
Interventions: Drug: Bledilait Biofer®;   Drug: Milk supplemented with ferrous sulphate;   Drug: Blédilait Biofer®
10 Completed
Has Results
Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Conditions: Iron Deficiency Anaemia;   Chronic Kidney Disease
Interventions: Drug: FCM (Ferric carboxymaltose) high ferritin target;   Drug: FCM (Ferric carboxymaltose) low ferritin target;   Drug: Oral Iron (Ferrous sulphate)
11 Unknown  Effect Of Intravenous Iron Versus Placebo On Muscle Oxidative Capacity And Physical Performance In Non Anemic Premenopausal Women With Low Ferritin Levels
Condition: Non Anemic Patients With Iron Deficiency (Low Ferritin Value)
Intervention: Drug: Double blind, randomized, placebo controlled inter
12 Unknown  An Algorithm to Start Iron Chelation in Minimally Transfused Young Beta-thalassemia Major Patients
Condition: Beta Thalassemia Major
Intervention: Drug: Deferiprone
13 Completed
Has Results
Iron Indices and Intravenous Ferumoxytol: Time to Steady State
Condition: Iron Deficiency Anemia
Intervention: Drug: ferumoxytol
14 Recruiting Intravenous Iron for Correction of Anaemia After Colorectal Surgery
Conditions: Anemia, Iron-Deficiency;   Intravenous Drug Usage;   Colorectal Neoplasms;   Colorectal Surgery
Interventions: Drug: Iron isomaltoside;   Drug: Saline
15 Completed Timing of Iron Supplementation in Very Low Birth Weight Infants
Condition: Nutritional Status
Intervention: Drug: Elemental iron
16 Completed Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis
Conditions: Chronic Anemia;   Transfusional Hemosiderosis
Intervention: Drug: Deferasirox (ICL670)
17 Completed Does the Reduction of Total Body Iron Storage (TBIS) Alter Mortality in a Population of Patients With Advanced PVD?
Conditions: Atherosclerosis;   Intermittent Claudication;   Peripheral Vascular Diseases
Intervention: Procedure: Ferritin reduction to 25 ng/ml by phlebotomy
18 Unknown  Erythrocytapheresis Versus Phlebotomy as Maintenance Therapy in Hereditary Hemochromatosis (HH) Patients
Condition: Hereditary Hemochromatosis
Intervention: Other: Phlebotomy and erythrocytapheresis
19 Unknown  Study Of Efficacy,Safety of Combined Deferasirox and Deferiprone Versus Combined Deferiprone and Desferal In Conditions of Iron Overload
Conditions: Beta-thalassemia Major;   Sickle Cell Disease;   Iron Hemosiderosis
Interventions: Drug: DFP (ferriprox) and deferasirox (ICL 670);   Drug: DFP, DFO
20 Recruiting Ferric Citrate in ESRD Pilot Project
Conditions: End Stage Renal Disease;   Chronic Kidney Diseases
Intervention: Drug: Ferric Citrate

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.